TerraVia Holdings, Inc. (formerly Solazyme) was a publicly held biotechnology company in the United States. TerraVia used proprietary technology to transform a range of low-cost plant-based sugars into high-value oils and whole algae ingredients. TerraVia supplies a variety of sustainable algae-based food ingredients to a number of brands, which have included Hormel Food Corporation, Utz Quality Foods Inc., and Enjoy Life Foods. TerraVia also sold its own culinary algae oil under the Thrive Algae Oil brand.

Laboratorios Aidelos SL is a biotechnology company that develops and designs equipment for health laboratories. It focuses on research and development activity in the field of forensics and human health. It supplies its products to the health, laboratory, and diagnostic sectors. The company was founded in 2004 and is headquartered in Derio, Spain.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

TCL Technology is one of China's largest enterprise groups of consumer electronics on global scale, owns four listed companies: TCL Technology Group Corporation ("TCL Technology"; SZSE stock code: 000100), TCL Electronics Holdings Limited ("TCL Electronics"; HKEX stock code: 1070), TCL Communication Technology Holdings Limited ("TCL Communication"; HKEX stock code: 2618), China Display Optoelectronics Technology Holdings Limited ("China Display"; HKEX stock code: 334) and Tonly Electronics Holdings Limited ("Tonly Electronics"; HKEX stock code: 1249), with major consumer products including: color TV, mobile phone, air conditioners, refrigerators, washing machines, small appliances and so on.Currently, TCL has formed five industry groups of TCL Electronics, TCL Communication, CSOT, TCL Home Appliance and Tonly Electronics, as well as System Technology Business Division, Techne Group, Emerging Business Group, Investment Group, Highly Information Industry, Financial Business Division and other business segments. TCL was founded in 1981. After 30 years of development, TCL has rapidly developed to be the leader of China's electronic information industry from the start, in the trend of China's reform and opening up, with dedication and innovation. In 2014 TCL brand value is 66.859 billion yuan, continuing to be the first brand of Chinese color TV industry. TCL Technology technological innovation system is composed of Industrial Technology Research Institute, Technology Center, as well as 28 R & D centers of subordinate industries. Currently, it has nearly 5,300 high-quality R & D personnel in the world, of which the staff with middle and senior technical title accounts for 42%, with more than 7000 sets of development software, instruments and equipments at international advanced level; over 100,000 square meters of R & D office; nine labs accredited and certified by CNAL national product; six joint laboratories with internationally renowned companies; one postdoctoral station. In 2013, the Group is expected to invest 2.3 billion yuan in R & D. TCL Technology is one of the few global enterprises with multimedia, mobile communications and 8.5-generation LCD panel. The company will give full play to synergies in products, research and development and management of TCL Electronics, TCL Communication and CSOT by integrating resources, and actively seek substantive breakthroughs in intelligent products, cloud computing and network technology applications, operating systems and application software and new display technologies, continue to strengthen the strength and thickness of technological innovation to enhance the overall competitive advantage of the company and TCL brand in the international consumer electronics industry. TCL Technology has formed the technology research and development system managed by the Group’s Technology and Patent Management Committee, with core technology research and development led by the Industrial Technology Research Institute, the technology center as management platform, and composed of 23 R & D institutions worldwide. TCL’s Industrial Technology Research Institute is directly under TCL headquarters, which are both the central R & D department and incubator of TCL core technologies. Around the two strategic directions of "3C Integrated Digital Home Systems and Infrastructure Software Platform Development" and "new display technology", the Institute focuses on the research of intelligent terminal technology, digital video and algorithm-based software technology platform, cloud framework and cloud computing, innovative products and services, relying on user experience research, to continue the exploration and development of new products and technologies.

Suzhou Bojin Biotechnology Co., Ltd. is a Chinese company. The firm operates as a biotechnology company which engages in drug separation and purification.

Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs. Their value chain extends from pre-clinical and clinical development to worldwide marketing and distribution. Biotest manufactures immunoglobulins, clotting factors and albumins which derive from human blood plasma. Biotest also develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus which are produced by recombinant technologies. Biotest currently employs more than 2,500 people worldwide. The most important raw material for their pharmaceuticals is human blood plasma, which they process into effective and highly purified drugs in one of their world leading fractionation facilities in Europe. These medications are used to treat life-threatening diseases such as blood coagulation disorders (haemophilia), severe infections and immune system disorders.

Part of Becton, Dickinson & Co., Becton, Dickinson & Co. Ltd. is an Irish company located in Dublin. The firm manufactures and supplies medical devices.

Takara Shuzo Co. Ltd. manufactures and markets alcoholic beverages. Its products include alcoholic beverages, raw alcohol, health drinks, and seasonings. The company was founded in 1925 and is headquartered in Kyoto, Japan.

Part of CSL Ltd., CSL Behring GmbH is a German company located in Marburg. The firm manufactures plasma protein bio therapeutics for the treatment of rare and major diseases. Michael Schröder, Lutz Guenter Bonacker and Craig Shelanskey are the current co-CEOs of the firm.

Hawon Pharmaceutical Co. Ltd. manufactures and wholesales pharmaceuticals. The firm's products include provides antispasmodics, fungicides, cerebral activators, muscle relaxants, and oral anti-diabetic agents. The company was founded in April 1981 and is headquartered in Seoul, South Korea.

ethris GmbH is a company headquartered in Planegg, Germany, that engages in researching and developing biotechnology. The firm was founded by Christian Plank and Carsten Rudolph. Carsten Rudolph is currently the CEO of the company.\nThe company says this about itself: Ethris has paved a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA technology platform to discover, design and develop innovative therapies. With more than a decade as an mRNA pioneer, we are a global leader in delivering stabilized mRNAs directly to the respiratory system via optimized formulation and nebulization technologies. We are rapidly approaching in vivo proof of concept for generating therapeutic antibodies against COVID-19 in the lung while advancing our pipeline of immuno-modulation and mRNA-based protein replacement therapies with the ultimate goal of improving patients? lives.

Designs lab instruments systems

PhaseRx is a startup company based in Seattle focused on the delivery of siRNA and other macromolecular therapeutics. The Company has attracted top-tier venture investors and was founded by its President, Robert Overell, Patrick Stayton and Allan Hoffman of the University of Washington, Oliver Press of Fred Hutchinson Cancer Research Center, and Paul Johnson, the Company's Chief Scientific Officer. PhaseRx was conceived on the basis of using novel polymer technology to deliver siRNA. The Company believes the technology also has significant applications for the delivery of other macromolecular therapeutics.

Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Wuxi Baiyun Nano Technology Co., Ltd., established on 2010-07-26, Business scope includes research and development of new nano-materials and chemical products,technology transfer,Technical Consulting and Technical Services;Chemical Products(Does not contain dangerous goods)promotion of;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);Production of Bioceramic Microspheres.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Hangzhou Advanced Biotechnology Co., Ltd., established on 2014-05-04, Business scope includes care solution filling production;hygiene products(anti-(suppress)Bacterial preparation(spray,liquid)(purify))Production;Biotechnology,Technology development in medical technology,technical consulting,Technical Services,Achievement transfer;cosmetic,Daily necessities,Instrumentation,disinfectant,Dental materials,Medical and health materials and products,laboratory equipment(In addition to pathology,Case and diagnostic equipment),chemical reagent(Removal of hazardous chemicals and precursor chemicals)promotion of;No.Iclass of medical devices,Production of instrumentation,Sales;Import and export(law,Except for items prohibited by administrative regulations;law,Projects that are restricted by administrative regulations can only be operated after obtaining a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)